CD274 and cancer: In many cancer types, T-cell activation is inhibited by the programmed death receptor 1 (PD-1), which can interact with programmed death ligand 1 (PD-L1), over-expressed on cancer cells, leading to escape of these cancers from immune surveillance [1,2].